RSPH

Invesco S&P 500 Equal Weight Health Care ETF

HealthcarePSEInvesco ETF
$37.45
$-0.42 (-1.11%)
Delayed ≥20 min · Sep 3, 2026

Key Statistics

Net Assets (AUM)
$864.72M
Expense Ratio
See prospectus
Previous Close
$37.87
Day Range
- – -
52-Week Range
$28.26 – $38.19
Volume
61.72K
Avg Vol (50D)
98.43K
Beta
0.78

Historical Performance

1M
+6.27%
3M
+18.15%
6M
+19.35%
YTD
+18.04%
1Y
+28.83%
3Y
+33.75%
5Y
+20.84%

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Moderna, Inc. 2.48%
Invesco Private Prime Fund 1.92%
Gilead Sciences, Inc. 1.91%
Merck & Co., Inc. 1.85%
Viatris Inc. 1.85%
Centene Corp. 1.83%
Molina Healthcare, Inc. 1.83%
Johnson & Johnson 1.80%
Baxter International Inc. 1.80%
Cardinal Health, Inc. 1.77%
Amgen Inc. 1.77%
DexCom, Inc. 1.77%
Charles River Laboratories International, Inc. 1.77%
Bristol-Myers Squibb Co. 1.76%
Zoetis Inc. 1.73%
Vertex Pharmaceuticals Inc. 1.73%
Bio-Techne Corp. 1.72%
Cencora, Inc. 1.72%
Revvity, Inc. 1.72%
Incyte Corp. 1.72%
Stryker Corp. 1.71%
Eli Lilly and Co. 1.71%
Cigna Group (The) 1.71%
Quest Diagnostics Inc. 1.70%
HCA Healthcare, Inc. 1.70%

Top 25 holdings as of Jan 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About RSPH

The Fund generally will invest at least 90% of its total assets in securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (“S&P DJI” or the “Index Provider”) compiles, maintains and calculates the Underlying Index, which is composed of all of the components of the S&P 500® Health Care Index (the “Parent Index”). The Parent Index is designed to measure the performance of common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (“GICS®”). The health care sector includes health care providers and services, companies that manufacture and distribute health care equipment and supplies, health care technology companies and companies involved in the research, development, production and marketing of pharmaceuticals and biotechnology products and life sciences tools and services. The Underlying Index is an equal-weighted version of the Parent Index. “Equal weighting” means that, unlike the Parent Index, which employs a float-adjusted market capitalization weighted methodology, the Underlying Index assigns each component security the same weight at each quarterly rebalance. As of June 30, 2024, the Underlying Index was comprised of 63 constituents with market capitalizations ranging from $6.4 billion to $860.5 billion. The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.Concentration Policy. The Fund will concentrate its investments (i.e., invest more than 25% of the value of its net assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of April 30, 2024, the Fund had significant exposure to the health care sector. The Fund’s portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.

Data for RSPH is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.